Granules India’s Unit V Facility Receives US FDA EIR with No Action Indicated Status
Mumbai, November 8, 2024: Granules India Limited, a leading pharmaceutical manufacturing company, is pleased to announce that it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its […]
